How Bayer Consumer Healthcare is Involved in Microbiome Research

Staff editor

08.09.2022

Holger Lenz discusses the interest of Bayer in the microbiome space during Microbiome Connect: Europe 2022.

Holger Lenz, Emerging Science & Innovation Director Dermatology at Bayer, discussed with us the interest of Bayer in the microbiome space during the Microbiome Connect: Europe 2022.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

How Bayer Consumer Healthcare is Involved in Microbiome Research

Latest related content

New tools reveal insights into Bifidobacterium’s role in gut health

The microbiome isn’t a trend. It’s the health OS we’ve been missing

Delayed gut microbiota maturation in cystic fibrosis may contribute to health issues

How exercise boosts gut health, helping prevent chronic diseases

Restoring vaginal health: Jacques Ravel on Live Biotherapeutics with Lactobacillus crispatus

Engineered viruses target gut bacteria to deliver drugs for inflammation and obesity

Latest News